Steven J. Goulart is executive vice president and chief investment officer of MetLife, Inc. and president of MetLife Investment Management. Named to this position in May 2011, Goulart oversees MetLife’s $669 billion total assets under management1 and more than 900 investment and support professionals around the world.
In 2012, he led the development and launch of MetLife Investment Management (MIM), MetLife’s institutional investment management business, and serves as its President. In August 2017, he oversaw the separation and subsequent transition of Brighthouse Financial, Inc.’s $80 billion investment portfolio management to MIM, and the successful acquisition of Logan Circle Partners in September 2017.
Prior to becoming CIO, Goulart served as senior managing director and head of MIM's portfolio management unit since January 2011. He joined MetLife in 2006 to head the company’s mergers & acquisitions unit, and in 2009 was also named treasurer. In these roles, he was responsible for the strategic management of MetLife’s financial resources, including capital planning and financings, risk-based capital management, liquidity and cash management, international treasury and mergers and acquisitions. In these key finance positions, Goulart oversaw the completion of capital financings exceeding $21 billion and more than fifteen strategic transactions, including MetLife’s successful $16.4 billion acquisition of Alico and the innovative tax-free split-off of MetLife’s majority stake in Reinsurance Group of America, Incorporated.
Prior to joining MetLife, Goulart was a senior managing director in Bear Stearns’ financial institutions group. Prior to joining Bear Stearns in 2001, he was managing director in Morgan Stanley’s global insurance group, where he co-led U.S. client coverage of the industry. Prior to joining Morgan Stanley in 1998, he was managing director in the financial institutions group at Merrill Lynch, where he had been since 1984, beginning in the fixed income division. Over the course of his career, Goulart has led or participated in many transactions in the financial services industry, including insurance company demutualizations, mergers and acquisitions, equity and debt offerings and initial public offerings.
Goulart received a Bachelor of Science in business administration from the University of Pacific, where he was elected to the Pacific Athletic Hall of Fame and served as a member of the board of regents for nine years. He earned his MBA from Harvard Business School. He serves as a member of the board of trustees for Tri-County Scholarship Fund and of the board of directors for the MetLife Foundation.
What is Steven J. Goulart's net worth?
The estimated net worth of Steven J. Goulart is at least $22.24 million as of December 12th, 2022. Mr. Goulart owns 273,310 shares of MetLife stock worth more than $22,236,502 as of December 21st. This net worth approximation does not reflect any other investments that Mr. Goulart may own. Learn More about Steven J. Goulart's net worth.
How do I contact Steven J. Goulart?
Has Steven J. Goulart been buying or selling shares of MetLife?
Steven J. Goulart has not been actively trading shares of MetLife within the last three months. Most recently, Steven J. Goulart sold 29,401 shares of the business's stock in a transaction on Monday, December 12th. The shares were sold at an average price of $71.88, for a transaction totalling $2,113,343.88. Following the completion of the sale, the executive vice president now directly owns 273,310 shares of the company's stock, valued at $19,645,522.80. Learn More on Steven J. Goulart's trading history.
Who are MetLife's active insiders?
Are insiders buying or selling shares of MetLife?
In the last twelve months, insiders at the financial services provider sold shares 2 times. They sold a total of 31,026 shares worth more than $2,240,759.40. The most recent insider tranaction occured on March, 18th when EVP Bill Pappas sold 27,000 shares worth more than $1,951,290.00. Insiders at MetLife own 0.3% of the company.
Learn More about insider trades at MetLife. Information on this page was last updated on 3/18/2024.